165 related articles for article (PubMed ID: 20944044)
1. Ocular side effects of bisphosphonates: A case report and literature review.
McKague M; Jorgenson D; Buxton KA
Can Fam Physician; 2010 Oct; 56(10):1015-7. PubMed ID: 20944044
[No Abstract] [Full Text] [Related]
2. [Osteoporosis and bisphosphonates].
Zuber MA
Z Rheumatol; 2007 Dec; 66(8):713-5. PubMed ID: 17955251
[No Abstract] [Full Text] [Related]
3. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
Iwamoto J; Takeda T; Sato Y
Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
[TBL] [Abstract][Full Text] [Related]
4. Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis.
Ringe JD; Möller G
Rheumatol Int; 2009 Dec; 30(2):213-21. PubMed ID: 19430791
[TBL] [Abstract][Full Text] [Related]
5. [Treating with what? Therapy for how long?].
MMW Fortschr Med; 2005 Dec; 147(51-52):62-3. PubMed ID: 16402713
[No Abstract] [Full Text] [Related]
6. Bisphosphonates for Postmenopausal Osteoporosis.
Ensrud KE
JAMA; 2021 Jan; 325(1):96. PubMed ID: 33399841
[No Abstract] [Full Text] [Related]
7. Bisphosphonates. A cornerstone of osteoporosis treatment.
Mayo Clin Womens Healthsource; 2007 May; 11(5):1-2. PubMed ID: 17476171
[No Abstract] [Full Text] [Related]
8. Pharmacology: Discontinuation of bisphosphonates.
Malden N; Loh S
Br Dent J; 2017 Jan; 222(2):67-8. PubMed ID: 28127004
[No Abstract] [Full Text] [Related]
9. [Questions and answers about bisphosphonates].
Letonturier P
Presse Med; 2007 Mar; 36(3 Pt 1):440. PubMed ID: 17436449
[No Abstract] [Full Text] [Related]
10. Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): additional results from the Monthly Oral Therapy With Ibandronate For Osteoporosis Intervention (MOTION) study.
Emkey R; Delmas PD; Bolognese M; Borges JL; Cosman F; Ragi-Eis S; Recknor C; Zerbini CA; Neate C; Sedarati F; Epstein S
Clin Ther; 2009 Apr; 31(4):751-61. PubMed ID: 19446148
[TBL] [Abstract][Full Text] [Related]
11. Going on a drug holiday?
Bonnick SL
J Clin Densitom; 2011; 14(4):377-83. PubMed ID: 22051091
[No Abstract] [Full Text] [Related]
12. [Postmenopausal osteoporosis. Bisphosphonates are not all equal].
MMW Fortschr Med; 2009 Mar; 151(11):46-7. PubMed ID: 19469206
[No Abstract] [Full Text] [Related]
13. Systematic review and meta-analysis of the efficacy and safety of alendronate and zoledronate for the treatment of postmenopausal osteoporosis.
Serrano AJ; Begoña L; Anitua E; Cobos R; Orive G
Gynecol Endocrinol; 2013 Dec; 29(12):1005-14. PubMed ID: 24063695
[TBL] [Abstract][Full Text] [Related]
14. The use of bisphosphonates in women: when to use and when to stop.
Gatti D; Adami S; Viapiana O; Rossini M
Expert Opin Pharmacother; 2015; 16(16):2409-21. PubMed ID: 26357942
[TBL] [Abstract][Full Text] [Related]
15. Safety of bisphosphonates in women of child bearing age.
McKenna M; Mansfield JC
Aliment Pharmacol Ther; 2009 Jun; 29(11):1214-5; author reply 1215-6. PubMed ID: 19473128
[No Abstract] [Full Text] [Related]
16. Alendronate and atrial fibrillation.
Cummings SR; Schwartz AV; Black DM
N Engl J Med; 2007 May; 356(18):1895-6. PubMed ID: 17476024
[No Abstract] [Full Text] [Related]
17. Pharmaceutical care issues encountered by post-menopausal osteoporotic women prescribed bisphosphonates.
Lai PS; Chua SS; Chan SP
J Clin Pharm Ther; 2012 Oct; 37(5):536-43. PubMed ID: 22380577
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates in osteoporosis: NICE and easy?
Harvey NC; McCloskey E; Kanis JA; Compston J; Cooper C
Lancet; 2017 Nov; 390(10109):2243-2244. PubMed ID: 29165263
[No Abstract] [Full Text] [Related]
19. Bisphosphonate-associated atypical subtrochanteric femur fractures in the older patient.
Gopal GK; Tam KL; Krishnan SP; Maddern IL
N Z Med J; 2014 Feb; 127(1389):81-5. PubMed ID: 24548959
[TBL] [Abstract][Full Text] [Related]
20. [Inflammation of the jaws during treatment with bisphosphonates].
Bartl R
Dtsch Med Wochenschr; 2011 Oct; 136(41):2109-10. PubMed ID: 21971888
[No Abstract] [Full Text] [Related]
[Next] [New Search]
